LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Piehler, Britt ^a   Nelson, Elizabeth K ^a   Eckels, Josh ^a   Ramsay, Sarah ^b   Lum, Karl ^a   Wood, Blake ^b   Greene, Kelli M ^c   Gao, Hongmei ^c   Seaman, Michael S ^d   Montefiori, David C ^c   Igra, Mark ^a  

^a LabKey Software   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; CALCULATION; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DATA BASE; HEMODILUTION; IMMUNOASSAY; INFORMATION PROCESSING; LABKEY SERVER NAB; LUMINESCENCE; NONHUMAN; ANIMAL; COMPUTER PROGRAM; HIGH THROUGHPUT SCREENING; HUMAN; INFORMATION DISSEMINATION; INFORMATION RETRIEVAL; SERODIAGNOSIS; STANDARD; STATISTICS;

ANIMALS; DATABASES AS TOPIC; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INFORMATION DISSEMINATION; INFORMATION STORAGE AND RETRIEVAL; NEUTRALIZATION TESTS; SOFTWARE; STATISTICS AS TOPIC;

EID: 79957521397     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-33     Document Type: Article

References (21)

1. Montefiori DC. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol 2005, Chapter 12:Unit 12.11..
2. Combita A, Touze A, Bousarghin L, Christensen ND, Coursaget P. Identification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses. J Virol 2002, 76:6480-6486. 10.1128/JVI.76.13.6480-6486.2002, 136273, 12050360.
3. Okuma K, Nakamura M, Nakano S, Niho Y, Matsuura Y. Host Range of Human T-Cell Leukemia Virus Type I Analyzed by a Cell Fusion-Dependent Reporter Gene Activation Assay. Virology 1999, 254:235-244. 10.1006/viro.1998.9530, 9986790.
4. Lam R, Farrell R, Aziz T, Gibbs E, Giovannoni G, Grossberg S, Oger J. Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFN[beta] in multiple sclerosis patients. Journal of Immunological Methods 2008, 336:113-118. 10.1016/j.jim.2008.03.014, 18511063.
5. Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R, Goudsmit J, Havenga MJE, Kostense S. Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors. J Clin Microbiol 2003, 41:5046-5052. 10.1128/JCM.41.11.5046-5052.2003, 262545, 14605137.
6. Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BTM, Hunter E, Hahn BH, Montefiori DC. Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa. J Virol 2006, 80:11776-11790. 10.1128/JVI.01730-06, 1642599, 16971434.
7. Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies. J Virol 2005, 79:10108-10125. 10.1128/JVI.79.16.10108-10125.2005, 1182643, 16051804.
8. Alam SM, Scearce RM, Parks RJ, Plonk K, Plonk SG, Sutherland LL, Gorny MK, Zolla-Pazner S, VanLeeuwen S, Moody MA, Xia S, Montefiori DC, Tomaras GD, Weinhold KJ, Karim SA, Hicks CB, Liao H, Robinson J, Shaw GM, Haynes BF. Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection. J Virol 2008, 82:115-125. 10.1128/JVI.00927-07, 2224348, 17942537.
9. Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, Self SG, Korber BT, Montefiori DC, Mascola JR. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies. J Virol 2010, 84:1439-1452. 10.1128/JVI.02108-09, 2812321, 19939925.
10. Nelson EK, Piehler B, Eckels J, Rauch A, Bellew M, Hussey P, Ramsay S, Nathe C, Lum K, Krouse K, Stearns D, Connolly B, Skillman T, Igra M. LabKey Server: An open source platform for scientific data integration, analysis and collaboration. BMC Bioinformatics 2011, 12:71. 10.1186/1471-2105-12-71, 3062597, 21385461.
11. Rauch A, Bellew M, Eng J, Fitzgibbon M, Holzman T, Hussey P, Igra M, Maclean B, Lin CW, Detter A, Fang R, Faca V, Gafken P, Zhang H, Whiteaker J, Whitaker J, States D, Hanash S, Paulovich A, McIntosh MW. Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res 2006, 5:112-121. 10.1021/pr0503533, 16396501.
12. Global HIV Vaccine Enterprise. , http://www.hivvaccineenterprise.org/
13. Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan. PLoS Med 2005, 2:e25. 544553, 15740411, Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise.
14. LabKey Server NAb Assay Tutorial. , https://www.labkey.org/wiki/home/Documentation/page.view?name=nabAssayTutorial
15. Johnson V, Byington R. Infectivity assay (virus yield assay). Techniques in HIV Research 1990, 71-76. New York, N.Y.: Stockton Press.
16. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes in C++: The Art of Scientific Computing 2002, Cambridge University Press, 2.
17. Gottschalk PG, Dunn JR. The five-parameter logistic: a characterization and comparison with the four-parameter logistic. Anal. Biochem 2005, 343:54-65. 10.1016/j.ab.2005.04.035, 15953581.
18. Atlas Science Portal. , https://atlas.scharp.org/cpas/project/home/begin.view?
19. Weiss-Sattentau-CN54 CAVD Study: Run 234272 Details. , https://atlas.scharp.org/cpas/nabassay/VISC/Montefiori-VIMC/Preclinical%20NAb-Seaman/Archive%20studies/Sattentau_HA1/details.view?rowId=234272&_print=true
20. CAVD Study Design Browser. , https://atlas.scharp.org/cpas/viscstudies/VISC/Completed%20CAVD%20Studies/studydesigns.view?
21. Apache License, Version 2.0. , http://www.apache.org/licenses/LICENSE-2.0.html